The ‘female Viagra’ goes hits the shelves today, fears of side effects...

The ‘female Viagra’ goes hits the shelves today, fears of side effects persist

1682
0
SHARE
FILE - In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Government health experts on Thursday, June 4, 2015 backed the approval of the experimental drug intended to boost the female sex drive, but stress that it should carry safety restrictions to manage side effects including fatigue, low blood pressure and fainting. (AP Photo/Allen G. Breed, File)

Women with low sexual drive will not rush to get the female libido boosting drug when it becomes available. Addyi is the name of the drug which has been approved for use as a female libido boosting device. However the drug has a sundry history of rejection by the FDA and questions are being asked about its adverse effects which far outweigh the benefits which are supposed to be accrued from the drug. However there are a class of experts who do not support Addyi yet but feel that it will spur development for better treatments for women’s sexual problem.

On Saturday Addyi, also known as female Viagra became available for sale. While it is being hailed as a big step forward in enabling women to express their sexuality there are no dearth of critics who denounce the drug for its safety and lack of testing in women. Addyl was rejected twice by FDA but this time the manufacturer of the drug, Sprouts, embarked on an aggressive promotional push. It signed up woman’s group’s to project Addyl as a feminist approved libido boosting drug. The minimal effectiveness and horrific side effects when used with alcohol was all brushed under the carpet.

An impassioned female CEO, support from Congressmen and numerous feminists succeeded in getting the nod from FDA for Addyl. Working against the approval was more than 200 fiercely critical scientists who felt that all the effort was in vain, crushed under corporate greed and manipulations.

The history of the drug is even more dubious. In 1999 well known German Drug manufacturer Boehringer Ingelheim tested a new drug, an antidepressant. However the tests failed miserably except for one silver lining. Female patients reported a slight boost in sexual urge after taking the drug. Boehringer Ingelheim had stumbled upon a treatment of a disease which has started affecting a number of women, a condition known as Hypoactive Sexual Desire Disorder, or HSDD with no identifiable cause known. The small pink pill called flibanserin, now Addyi

Viagra was launched and most pharmaceutical giants were scrambling to replicate the success story of Viagra. What followed was a 15 year journey of rejection, ownership changes, heated and divisive debates within the scientific community. In a last ditch effort Sprout managed to tip the balance in its favor with some aggressive lobbying and marketing.

SHARE
Previous articleNASA’s images show a gigantic coronal hole 50 times the size of Earth
Next articleWhy Mankind's Survival May Depend on Colonizing Mars

Mable Watson Originally belongs to Dallas, Texas now settled in South Dakota. Mable graduated from University Of North Texas. She works like no other writer would ever imagine. She scans the headlines and notes only a single word, later on works for hours. Everything she has scanned once goes into her brain and she has trained herself that way. Being a lead editor she has worked in the Social Science arena for almost 9 years. Her writing style is simple yet so different from others that you can’t help appreciating. Email : mable@dailysciencejournal.com